Abstract

Objective To observe the effect of metoprolol combined with trimetazidine on the serum levels of inflammatory factor and immune function in elderly patients with coronary artery heart disease combined with heart failure. Methods Ninety-four elderly patients with coronary heart disease and heart failure were randomly divided into group A and group B, 47 cases in each group. Group A received metoprolol on the basis of routine treatment, while group B received trimetazidine on the basis of group A. The total effective rate of the two groups was counted, and the levels of CRP, CD4+ , CD8+ before and after treatment were compared between the two groups. Results The total effective rate of group B (95.74%) was higher than that of group A (80.85%), and the difference was statistically significant (P<0.05). After treatment, the CRP level of both groups decreased significantly (P<0.05), while that of group B was lower than that of group A (P<0.05). After treatment, the CD4+ level of group B was higher than that of group A (P<0.05). Conclusion Metoprolol combined with trimetazidine in the treatment of elderly patients with coronary heart disease complicated with heart failure has a good clinical effect, can effectively reduce inflammation, improve immune function, and has clinical popularization value. Key words: Coronary heart disease; Heart failure; Metoprolol; Trimetazidine

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.